Genomics

Dataset Information

High efficacy of combined MEK Inhibitor Trametinib and RTK Inhibitor Anlotinib Therapy in KRAS-Mutant Lung Cancer


ABSTRACT: High efficacy of combined MEK Inhibitor Trametinib and RTK Inhibitor Anlotinib Therapy in KRAS-Mutant Lung Cancer

PROVIDER: PRJNA1039260 | ENA |

REPOSITORIES: ENA